Federated Hermes, Inc. Immuno Gen, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$14.09 - $19.87 $2,536 - $3,576	-180 Reduced 22.81%	609 $9,000
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $2,917 - $15,598	778 Added 7072.73%	789 $14,000
Q1 2023 May 08, 2023	BUY	$3.67 - $4.92 $7 - $9	2 Added 22.22%	11 $0
Q4 2022 Feb 13, 2023	BUY	$4.55 - $6.31 $18 - $25	4 Added 80.0%	9 $0
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $156 - $226	-35 Reduced 87.5%	5 $1,000
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $119 - $218	38 Added 1900.0%	40 $2,000
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $4 - $7	1 Added 100.0%	2 $1,000
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $4 - $7	1 New	1 $1,000
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $773,295 - $1.02 Million	-154,043 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $2.23 Million - $3.31 Million	-384,712 Reduced 71.41%	154,043 $1.02 Million
Q1 2021 May 13, 2021	BUY	$6.5 - $10.53 $3.5 Million - $5.67 Million	538,233 Added 103109.77%	538,755 $4.36 Million
Q4 2020 Feb 12, 2021	SELL	$3.7 - $7.66 $39,678 - $82,145	-10,724 Reduced 95.36%	522 $3,000
Q3 2020 Nov 12, 2020	SELL	$3.45 - $4.89 $1,193 - $1,691	-346 Reduced 2.98%	11,246 $40,000
Q2 2020 Aug 13, 2020	SELL	$3.32 - $5.34 $778,237 - $1.25 Million	-234,409 Reduced 95.29%	11,592 $54,000
Q1 2020 May 13, 2020	BUY	$2.12 - $6.8 $248,665 - $797,606	117,295 Added 91.13%	246,001 $839,000
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $288,333 - $743,258	128,148 Added 22965.59%	128,706 $657,000
Q3 2019 Nov 14, 2019	BUY	$2.22 - $3.39 $1,238 - $1,891	558 New	558 $2,000
Q3 2018 Nov 13, 2018	SELL	$8.6 - $11.26 $459,713 - $601,903	-53,455 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$9.52 - $12.15 $312,370 - $398,665	32,812 Added 158.95%	53,455 $520,000
Q1 2018 May 09, 2018	BUY	$6.7 - $12.95 $22,981 - $44,418	3,430 Added 19.93%	20,643 $217,000
Q4 2017 Feb 14, 2018	SELL	$5.07 - $7.92 $283,803 - $443,337	-55,977 Reduced 76.48%	17,213 $0
Q3 2017 Nov 13, 2017	BUY	$5.4 - $8.47 $395,226 - $619,919	73,190	73,190 $560,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account